(Q52190207)

26 April 2018

title

Developmental toxicity of carbendazim: comparison of no-observed-adverse-effect level and benchmark dose approach. (English)

1 reference

26 April 2018

1

A Mantovani

1 reference

26 April 2018

Francesca Maranghi

1 reference

ORCID Public Data File 2021

author name string

F Maranghi

2

1 reference

26 April 2018

C Ricciardi

3

1 reference

26 April 2018

C Macrì

4

1 reference

26 April 2018

A V Stazi

5

1 reference

26 April 2018

L Attias

6

1 reference

26 April 2018

G A Zapponi

7

1 reference

26 April 2018

publication date

1 January 1998

1 reference

26 April 2018

Food and Chemical Toxicology

published in

1 reference

26 April 2018

volume

36

1 reference

26 April 2018

issue

1

1 reference

26 April 2018

page(s)

37-45

1 reference

26 April 2018

Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Benchmark dose analysis of developmental toxicity in rats exposed to boric acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Calculation of benchmark doses from teratology data

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Benchmark Dose Workshop: criteria for use of a benchmark dose to estimate a reference dose.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Improved method for selection of the NOAEL

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

A new method for determining allowable daily intakes.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

On reference dose (RfD) and its underlying toxicity data base

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Characterization of a developmental toxicity dose-response model

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Application of benchmark dose risk assessment methodology to developmental toxicity: an industrial view.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Quantitative risk analysis for quantal reproductive and developmental effects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Application of the benchmark method to risk assessment of trichloroethene.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Effects observed on gestational day 13 in rat embryos exposed to albendazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Pharmacokinetic considerations in the design and interpretation of developmental toxicity studies

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Principles and problems in assessing prenatal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

Developmental toxicity NOAEL and postnatal recovery in rats fed boric acid during gestation.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2897%2900116-6

7 January 2021

10.1016/S0278-6915(97)00116-6

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018